Jazz Pharmaceuticals: Clinical Trials & FDA Approval Profile
Jazz Pharmaceuticals (Dublin, IE / Palo Alto, CA) sponsors 43 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 13 active protocols (11 recruiting now), 13 completed protocols, and 11 all-time original FDA Drugs@FDA NDA and BLA approvals.